相关实验视频
Updated: Sep 10, 2025

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
用于治疗精神分裂症的CobenfyTM:临床概述
精神分裂症的新疗法正在出现. 这篇文章概述了xanomeline和trospium化物 (CobenfyTM),这是治疗精神分裂症患者的精神病护士的创新选择.
科学领域:
- 精神病学
- 药理学
背景情况:
- 精神分裂症带来重大挑战,包括心理障碍,发病率和死亡率.
- 有效的管理需要对新兴治疗策略的认识.
研究的目的:
- 提供xanomeline和化 (CobenfyTM) 的概述.
- 为高级精神病护士提供创新的精神分裂症治疗方法.
主要方法:
- 本文简要介绍了这些药物.
主要成果:
- 克萨诺米林和化 (CobenfyTM) 是一种新的治疗方法.
结论:
- 高级精神病护士应该了解像CobenfyTM这样的创新治疗方法来治疗精神分裂症.
更多相关视频
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
07:16Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
相关概念视频
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...